THALLOUS CHLORIDE TL 201
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Dec 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
THALLOUS CHLORIDE TL 201 by Bracco is 201 with no carrier added accumulates in viable myocardium in a manner analogous to that of potassium. First approved in 1982.
Drug data last refreshed 3d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Thallous Chloride Tl 201 is a radioactive diagnostic agent approved in 1982 for myocardial perfusion imaging. It accumulates in viable myocardium analogous to potassium and is used to detect areas of infarction and transient ischemia during exercise stress testing. The agent visualizes regional coronary perfusion, identifying "cold" defects in infarcted regions and stenosis-related ischemia.
LOE Approaching
Legacy diagnostic product nearing loss of exclusivity with declining commercial footprint and minimal team expansion anticipated.
Mechanism of Action
201 with no carrier added accumulates in viable myocardium in a manner analogous to that of potassium. Experiments in healthy subjects using labeled microspheres have shown that the myocardial distribution of thallous chloride Tl 201 correlates with regional perfusion. In clinical studies, Thallous…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings reflect declining commercial prioritization and legacy product status. Roles on this product typically involve maintenance, compliance, and managed decline activities rather than growth and innovation.
Product Manager
Worked on THALLOUS CHLORIDE TL 201 at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.